Share Price and Basic Stock Data
Last Updated: June 24, 2025, 8:20 pm
| Market Cap | 2,574 Cr. |
|---|
| Current Price | 1,28,700 |
|---|
| High / Low | 3,32,400/0.00 |
|---|
| Stock P/E | 16.8 |
|---|
| Book Value | 4,58,426 |
|---|
| Dividend Yield | 0.02 % |
|---|
| ROCE | 1.98 % |
|---|
| ROE | 1.47 % |
|---|
| Face Value | 10.0 |
|---|
| PEG Ratio | 0.00 |
|---|
Stock P/E, Current Price, and Intrinsic Value Over Time
View Share Price Target for Elcid Investments Ltd
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|
| Sales | 3 | 64 | 32 | 28 | 3 | 128 | 23 | 60 | 23 | 178 | 56 | -5 | -17 |
| Expenses | 1 | 18 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
| Operating Profit | 2 | 45 | 30 | 26 | 1 | 128 | 22 | 59 | 22 | 176 | 55 | -6 | -21 |
| OPM % | 71% | 71% | 96% | 94% | 37% | 99% | 96% | 98% | 97% | 99% | 98% | | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 45 | 30 | 26 | 1 | 127 | 22 | 59 | 22 | 177 | 55 | -6 | -20 |
| Tax % | -35% | 30% | 26% | 26% | 141% | 24% | 29% | 22% | 28% | 23% | 22% | 14% | -2% |
| Net Profit | 3 | 32 | 22 | 19 | -0 | 97 | 16 | 46 | 16 | 136 | 43 | -7 | -20 |
| EPS in Rs | 128.00 | 1,578.50 | 1,115.00 | 958.00 | -18.50 | 4,870.50 | 778.00 | 2,311.00 | 796.00 | 6,797.50 | 2,173.50 | -344.50 | -977.00 |
Last Updated: May 31, 2025, 6:11 am
Below is a detailed analysis of the quarterly data for Elcid Investments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is -17.00 Cr.. The value appears to be declining and may need further review. It has decreased from -5.00 Cr. (Dec 2024) to -17.00 Cr., marking a decrease of 12.00 Cr..
- For Expenses, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Dec 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Mar 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Dec 2024) to -21.00 Cr., marking a decrease of 15.00 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Other Income, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -20.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Dec 2024) to -20.00 Cr., marking a decrease of 14.00 Cr..
- For Tax %, as of Mar 2025, the value is -2.00%. The value appears to be improving (decreasing) as expected. It has decreased from 14.00% (Dec 2024) to -2.00%, marking a decrease of 16.00%.
- For Net Profit, as of Mar 2025, the value is -20.00 Cr.. The value appears to be declining and may need further review. It has decreased from -7.00 Cr. (Dec 2024) to -20.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -977.00. The value appears to be declining and may need further review. It has decreased from -344.50 (Dec 2024) to -977.00, marking a decrease of 632.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:39 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
| Sales | 23 | 31 | 31 | 37 | 48 | 61 | 78 | 108 | 135 | 109 | 235 | 211 |
| Expenses | 0 | 0 | 1 | 1 | 1 | 2 | 6 | 1 | 3 | 6 | 3 | 6 |
| Operating Profit | 23 | 31 | 30 | 36 | 47 | 59 | 72 | 107 | 132 | 103 | 232 | 205 |
| OPM % | 99% | 99% | 98% | 98% | 98% | 97% | 92% | 99% | 98% | 94% | 99% | 97% |
| Other Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 23 | 31 | 30 | 36 | 47 | 59 | 72 | 107 | 131 | 102 | 232 | 206 |
| Tax % | 2% | 2% | 1% | 2% | 1% | 8% | -2% | 24% | 24% | 28% | 24% | 26% |
| Net Profit | 23 | 30 | 30 | 35 | 46 | 55 | 73 | 81 | 100 | 73 | 176 | 153 |
| EPS in Rs | 1,132.50 | 1,490.50 | 1,476.00 | 1,757.00 | 2,315.50 | 2,727.00 | 3,659.00 | 4,052.50 | 5,002.00 | 3,670.50 | 8,787.00 | 7,650.00 |
| Dividend Payout % | 1% | 1% | 1% | 1% | 1% | 1% | 0% | 0% | 0% | 1% | 0% | 0% |
Profit & Loss Yearly Chart
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|
| YoY Net Profit Growth (%) | 30.43% | 0.00% | 16.67% | 31.43% | 19.57% | 32.73% | 10.96% | 23.46% | -27.00% | 141.10% | -13.07% |
| Change in YoY Net Profit Growth (%) | 0.00% | -30.43% | 16.67% | 14.76% | -11.86% | 13.16% | -21.77% | 12.50% | -50.46% | 168.10% | -154.16% |
Elcid Investments Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth |
|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | -10% |
| Compounded Profit Growth |
|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 15% |
| TTM: | -13% |
| Stock Price CAGR |
|---|
| 10 Years: | % |
| 5 Years: | 577% |
| 3 Years: | 3721% |
| 1 Year: | 3650492% |
| Return on Equity |
|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
| Month | Month | | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
| Cash from Operating Activity + | 5 | -1 | -0 | 0 | -1 | -1 | -1 | 14 | 61 | 37 | 78 | 94 |
| Cash from Investing Activity + | -4 | 0 | 0 | 0 | 0 | 1 | 8 | -12 | -68 | -27 | -87 | -95 |
| Cash from Financing Activity + | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net Cash Flow | 0 | -1 | -0 | 0 | -1 | -0 | 6 | 2 | -7 | 10 | -10 | -1 |
|
Free Cash Flow Chart
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | | | | | | | | | | | | |
| Days Payable | | | | | | | | | | | | |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 112 | -5 | -3 | 2 | -2 | -3 | 2 | -0 | -14 | -40 | -32 | -18 |
| ROCE % | 22% | 22% | 23% | 18% | 18% | 20% | 2% | 1% | 1% | 1% | 1% | 2% |
Financial Efficiency Indicators Chart
Share Holding Pattern
| Month | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Public | 25.01% | 25.01% | 25.01% | 25.00% | 25.00% | 25.01% | 25.00% | 25.01% | 24.99% | 25.01% | 25.01% | 25.01% |
| No. of Shareholders | 276 | 281 | 285 | 283 | 286 | 292 | 299 | 301 | 307 | 321 | 328 | 2,763 |
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund.
ROCE Trend
EPS Trend
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7649.78 | 8786.77 | 3670.64 | 5001.94 | 4052.46 |
| Diluted EPS (Rs.) | 7649.78 | 8786.77 | 3670.64 | 5001.94 | 4052.46 |
| Cash EPS (Rs.) | 7704.97 | 8830.82 | 3709.15 | 5032.04 | 4066.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 458425.83 | 584225.19 | 559608.69 | 616440.32 | 508261.02 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 458425.83 | 584225.19 | 559608.69 | 616440.32 | 508261.02 |
| Revenue From Operations / Share (Rs.) | 10556.99 | 11763.58 | 5443.60 | 6738.89 | 5386.85 |
| PBDIT / Share (Rs.) | 10357.67 | 11623.42 | 5138.23 | 6583.41 | 5339.99 |
| PBIT / Share (Rs.) | 10302.49 | 11579.37 | 5099.73 | 6553.31 | 5326.26 |
| PBT / Share (Rs.) | 10302.49 | 11579.37 | 5099.73 | 6553.31 | 5326.26 |
| Net Profit / Share (Rs.) | 7649.78 | 8786.76 | 3670.64 | 5001.94 | 4052.47 |
| NP After MI And SOA / Share (Rs.) | 7649.78 | 8786.76 | 3670.64 | 5001.94 | 4052.47 |
| PBDIT Margin (%) | 98.11 | 98.80 | 94.39 | 97.69 | 99.13 |
| PBIT Margin (%) | 97.58 | 98.43 | 93.68 | 97.24 | 98.87 |
| PBT Margin (%) | 97.58 | 98.43 | 93.68 | 97.24 | 98.87 |
| Net Profit Margin (%) | 72.46 | 74.69 | 67.43 | 74.22 | 75.22 |
| NP After MI And SOA Margin (%) | 72.46 | 74.69 | 67.43 | 74.22 | 75.22 |
| Return on Networth / Equity (%) | 1.66 | 1.50 | 0.65 | 0.81 | 0.79 |
| Return on Capital Employeed (%) | 1.94 | 1.85 | 0.85 | 0.99 | 0.98 |
| Return On Assets (%) | 1.44 | 1.40 | 0.61 | 0.75 | 0.74 |
| Asset Turnover Ratio (%) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Current Ratio (X) | 100313.55 | 52903.02 | 44556.28 | 123574.74 | 2.16 |
| Quick Ratio (X) | 100313.55 | 52903.02 | 44556.28 | 123574.74 | 2.16 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.28 | 0.40 | 0.29 | 0.37 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.28 | 0.40 | 0.29 | 0.36 |
| Earning Retention Ratio (%) | 0.00 | 99.72 | 99.60 | 99.71 | 99.63 |
| Cash Earning Retention Ratio (%) | 0.00 | 99.72 | 99.60 | 99.71 | 99.64 |
| Enterprise Value (Cr.) | 2650.13 | -1.17 | -11.06 | -1.02 | -8.56 |
| EV / Net Operating Revenue (X) | 12.55 | 0.00 | -0.10 | -0.01 | -0.07 |
| EV / EBITDA (X) | 12.79 | -0.01 | -0.10 | -0.01 | -0.08 |
| MarketCap / Net Operating Revenue (X) | 12.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 99.71 | 99.59 | 99.70 | 99.62 |
| Price / BV (X) | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 12.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.05 | 2607.35 | 1199.56 | 294.23 | 274.93 |
After reviewing the key financial ratios for Elcid Investments Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7,649.78. This value is within the healthy range. It has decreased from 8,786.77 (Mar 24) to 7,649.78, marking a decrease of 1,136.99.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7,649.78. This value is within the healthy range. It has decreased from 8,786.77 (Mar 24) to 7,649.78, marking a decrease of 1,136.99.
- For Cash EPS (Rs.), as of Mar 25, the value is 7,704.97. This value is within the healthy range. It has decreased from 8,830.82 (Mar 24) to 7,704.97, marking a decrease of 1,125.85.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 458,425.83. It has decreased from 584,225.19 (Mar 24) to 458,425.83, marking a decrease of 125,799.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 458,425.83. It has decreased from 584,225.19 (Mar 24) to 458,425.83, marking a decrease of 125,799.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 10,556.99. It has decreased from 11,763.58 (Mar 24) to 10,556.99, marking a decrease of 1,206.59.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10,357.67. This value is within the healthy range. It has decreased from 11,623.42 (Mar 24) to 10,357.67, marking a decrease of 1,265.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10,302.49. This value is within the healthy range. It has decreased from 11,579.37 (Mar 24) to 10,302.49, marking a decrease of 1,276.88.
- For PBT / Share (Rs.), as of Mar 25, the value is 10,302.49. This value is within the healthy range. It has decreased from 11,579.37 (Mar 24) to 10,302.49, marking a decrease of 1,276.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7,649.78. This value is within the healthy range. It has decreased from 8,786.76 (Mar 24) to 7,649.78, marking a decrease of 1,136.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7,649.78. This value is within the healthy range. It has decreased from 8,786.76 (Mar 24) to 7,649.78, marking a decrease of 1,136.98.
- For PBDIT Margin (%), as of Mar 25, the value is 98.11. This value is within the healthy range. It has decreased from 98.80 (Mar 24) to 98.11, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 97.58. This value exceeds the healthy maximum of 20. It has decreased from 98.43 (Mar 24) to 97.58, marking a decrease of 0.85.
- For PBT Margin (%), as of Mar 25, the value is 97.58. This value is within the healthy range. It has decreased from 98.43 (Mar 24) to 97.58, marking a decrease of 0.85.
- For Net Profit Margin (%), as of Mar 25, the value is 72.46. This value exceeds the healthy maximum of 10. It has decreased from 74.69 (Mar 24) to 72.46, marking a decrease of 2.23.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 72.46. This value exceeds the healthy maximum of 20. It has decreased from 74.69 (Mar 24) to 72.46, marking a decrease of 2.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 15. It has increased from 1.50 (Mar 24) to 1.66, marking an increase of 0.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 10. It has increased from 1.85 (Mar 24) to 1.94, marking an increase of 0.09.
- For Return On Assets (%), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 1.40 (Mar 24) to 1.44, marking an increase of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Current Ratio (X), as of Mar 25, the value is 100,313.55. This value exceeds the healthy maximum of 3. It has increased from 52,903.02 (Mar 24) to 100,313.55, marking an increase of 47,410.53.
- For Quick Ratio (X), as of Mar 25, the value is 100,313.55. This value exceeds the healthy maximum of 2. It has increased from 52,903.02 (Mar 24) to 100,313.55, marking an increase of 47,410.53.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.28 (Mar 24) to 0.00, marking a decrease of 0.28.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.28 (Mar 24) to 0.00, marking a decrease of 0.28.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.72 (Mar 24) to 0.00, marking a decrease of 99.72.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.72 (Mar 24) to 0.00, marking a decrease of 99.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,650.13. It has increased from -1.17 (Mar 24) to 2,650.13, marking an increase of 2,651.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.55. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 12.55, marking an increase of 12.55.
- For EV / EBITDA (X), as of Mar 25, the value is 12.79. This value is within the healthy range. It has increased from -0.01 (Mar 24) to 12.79, marking an increase of 12.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 12.56. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 12.56, marking an increase of 12.56.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.71 (Mar 24) to 0.00, marking a decrease of 99.71.
- For Price / BV (X), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 24) to 0.28, marking an increase of 0.28.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.56. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 24) to 12.56, marking an increase of 12.56.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 2,607.35 (Mar 24) to 0.05, marking a decrease of 2,607.30.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Error: EPS data not available for calculation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elcid Investments Ltd:
- Net Profit Margin: 72.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.94% (Industry Average ROCE: 19.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.66% (Industry Average ROE: 13.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 100313.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.8 (Industry average Stock P/E: 76.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:
About the Company - Qualitative Analysis
Elcid Investments Ltd. is a Public Limited Listed company incorporated on 03/12/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L65990MH1981PLC025770 and registration number is 025770. Currently company belongs to the Industry of Finance & Investments. Company's Total Operating Revenue is Rs. 138.43 Cr. and Equity Capital is Rs. 0.20 Cr. for the Year ended 31/03/2025.
| Management |
|---|
| Name | Position Held |
|---|
| Mr. Varun Vakil | Chairman, Non Ind & Non Exe Director |
| Mr. Essaji Vahanvati | Non Exe. & Ind. Director |
| Mr. Kartikeya Kaji | Non Exe. & Ind. Director |
| Ms. Amrita Vakil | Non Exe. & Ind. Director |
FAQ: Stock data is invalid or not in the correct format.
